Fibrodysplasia ossificans progressiva, a heritable disorder of severe heterotopic ossification, maps to human chromosome 4q27-31

被引:68
作者
Feldman, G
Li, M
Martin, S
Urbanek, M
Urtizberea, JA
Fardeau, M
LeMerrer, M
Connor, JM
Triffitt, J
Smith, R
Muenke, M
Kaplan, FS
Shore, EM
机构
[1] Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA
[2] Univ Penn, Sch Med, Dept Orthopaed Surg, Philadelphia, PA 19104 USA
[3] Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA
[4] Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA
[5] Assoc Francaise Contre Myopathies, Inst Myol, Paris, France
[6] Hop Necker Enfants Malad, INSERM, U393, Paris, France
[7] Univ Glasgow, Sch Med, Inst Med Genet, Yorkhill Hosp, Glasgow, Lanark, Scotland
[8] Univ Oxford, Nuffield Orthopaed Ctr, Nuffield Dept Orthopaed Surg, Bone Res Lab, Oxford OX1 2JD, England
[9] Natl Human Genet Res Inst, Med Genet Branch, NIH, Bethesda, MD USA
关键词
D O I
10.1086/302724
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Fibrodysplasia ossificans progressiva (FOP) is a severely disabling, autosomal-dominant disorder of connective tissue and is characterized by postnatal progressive heterotopic ossification of muscle, tendon, ligament, and fascia and by congenital malformation of the great toes. To identify the chromosomal location of the FOP gene, we conducted a genomewide linkage analysis, using four affected families with a total of 14 informative meioses. Male-to-male transmission of the FOP phenotype excluded X-linked inheritance. Highly polymorphic microsatellite markers covering all human autosomes were amplified by use of PCR. The FOP phenotype is linked to markers located in the 4q27-31 region (LOD score 3.10 at recombination fraction 0). Crossover events localize the putative FOP gene within a 36-cM interval bordered proximally by D4S1625 and distally by D4S2417. This interval contains at least one gene involved in the bone morphogenetic protein-signaling pathway.
引用
收藏
页码:128 / 135
页数:8
相关论文
共 46 条
[1]   Human T cell lymphotropic virus type I Tax protein trans-activates interleukin 15 gene transcription through an NF-κB site [J].
Azimi, N ;
Brown, K ;
Bamford, RN ;
Tagaya, Y ;
Siebenlist, U ;
Waldmann, TA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (05) :2452-2457
[2]   Sox9 is required for cartilage formation [J].
Bi, WM ;
Deng, JM ;
Zhang, ZP ;
Behringer, RR ;
de Crombrugghe, B .
NATURE GENETICS, 1999, 22 (01) :85-89
[3]   THE NATURAL-HISTORY OF HETEROTOPIC OSSIFICATION IN PATIENTS WHO HAVE FIBRODYSPLASIA OSSIFICANS PROGRESSIVA - A STUDY OF 44 PATIENTS [J].
COHEN, RB ;
HAHN, GV ;
TABAS, JA ;
PEEPER, J ;
LEVITZ, CL ;
SANDO, A ;
SANDO, N ;
ZASLOFF, M ;
KAPLAN, FS .
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 1993, 75A (02) :215-219
[4]  
CONNOR JM, 1982, J MED GENET, V19, P35, DOI 10.1136/jmg.19.1.35
[5]   FIBRODYSPLASIA OSSIFICANS PROGRESSIVA - THE CLINICAL-FEATURES AND NATURAL-HISTORY OF 34 PATIENTS [J].
CONNOR, JM ;
EVANS, DAP .
JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME, 1982, 64 (01) :76-83
[6]   A 3 GENERATION FAMILY WITH FIBRODYSPLASIA OSSIFICANS PROGRESSIVA [J].
CONNOR, JM ;
SKIRTON, H ;
LUNT, PW .
JOURNAL OF MEDICAL GENETICS, 1993, 30 (08) :687-689
[7]  
Delatycki M, 1998, CLIN ORTHOP RELAT R, P15
[8]   Structure and function of steroid dehydrogenases involved in hypertension, fertility, and cancer [J].
Duax, WL ;
Ghosh, D .
STEROIDS, 1997, 62 (01) :95-100
[9]   Osf2/Cbfa1: A transcriptional activator of osteoblast differentiation [J].
Ducy, P ;
Zhang, R ;
Geoffroy, V ;
Ridall, AL ;
Karsenty, G .
CELL, 1997, 89 (05) :747-754
[10]  
Gannon FH, 1998, CLIN ORTHOP RELAT R, P19